“COVID-19 is gone, long live COVID” – this is not a proverb, thankfully so. But it could be, given that the global pharma industry is still drawing lessons from the pandemic caused by SARS-CoV-2 to prepare for the next one, which many in the scientific community say is inevitable.
A panel of officials from companies, regulators and multilateral organizations came together with scientists at a recent conference to consider how the ‘One Health’ methodology could work, among other things,...